Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan.

Article Details

Citation

Sidharta PN, Treiber A, Dingemanse J

Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan.

Clin Pharmacokinet. 2015 May;54(5):457-71. doi: 10.1007/s40262-015-0255-5.

PubMed ID
25860376 [ View in PubMed
]
Abstract

Pulmonary arterial hypertension (PAH) is a progressive disease of the lung vascular system, which leads to right-sided heart failure and ultimately death if untreated. Treatments to regulate the pulmonary vascular pressure target the prostacyclin, nitric oxide, and endothelin (ET) pathways. Macitentan, an oral, once-daily, dual ETA and ETB receptor antagonist with high affinity and sustained receptor binding is the first ET receptor antagonist to show significant reduction of the risk of morbidity and mortality in PAH patients in a large-scale phase III study with a long-term outcome. Here we present a review of the available clinical pharmacokinetic, pharmacodynamic, pharmacokinetic/pharmacodynamic relationship, and drug-drug interaction data of macitentan in healthy subjects, patients with PAH, and in special populations.

DrugBank Data that Cites this Article

Drugs
Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
CyclosporineCytochrome P450 3A4ProteinHumans
Unknown
Substrate
Inhibitor
Details
MacitentanCytochrome P450 2C19ProteinHumans
No
Substrate
Details
MacitentanCytochrome P450 2C8ProteinHumans
No
Substrate
Details
MacitentanCytochrome P450 2C9ProteinHumans
No
Substrate
Details
MacitentanCytochrome P450 3A4ProteinHumans
No
Substrate
Details
Drug Carriers
DrugCarrierKindOrganismPharmacological ActionActions
Macitentanalpha1-acid glycoprotein (Protein Group)Protein groupHumans
No
Binder
Details
MacitentanSerum albuminProteinHumans
No
Binder
Details
Drug Transporters
DrugTransporterKindOrganismPharmacological ActionActions
CyclosporineATP-binding cassette sub-family G member 2ProteinHumans
Unknown
Inhibitor
Details
CyclosporineSolute carrier family 22 member 6ProteinHumans
Unknown
Substrate
Inhibitor
Details
CyclosporineSolute carrier organic anion transporter family member 1B3ProteinHumans
No
Inhibitor
Details
Drug Reactions
Reaction
Details
Details
Details
Details